Woodline Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.9M Buy
226,640
+158,232
+231% +$13.4M 0.06% 394
2026
Q1
$5.89M Buy
+68,408
New +$6.14M 0.02% 632
2024
Q4
Sell
-143,699
Closed -$10.3M 960
2024
Q3
$10.3M Buy
143,699
+5,171
+4% +$365K 0.09% 290
2024
Q2
$9.49M Buy
+138,528
New +$8.28M 0.09% 253

Other funds holding GMED

Woodline Partners's GMED Position: Q2 2026 in Review

Woodline Partners increased its Globus Medical (GMED) stake by 231% in Q2 2026, buying an estimated $13.4M and bringing the position to 226,640 shares worth $17.9M. The position accounts for 0.06% of the portfolio, ranked #394.

Woodline Partners first reported a position in GMED in Q2 2024 and has held it in 4 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Woodline Partners held 226,640 shares of Globus Medical worth $17.9M as of Q2 2026.
  • Woodline Partners bought 158,232 Globus Medical shares in Q2 2026, an estimated $13.4M.
  • Globus Medical made up 0.06% of Woodline Partners's portfolio in Q2 2026, its #394 holding.
  • Woodline Partners first reported a position in Globus Medical in Q2 2024 and has held it in 4 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.